X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Wockhardt with SHASUN PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT LTD. vs SHASUN PHARMA - Comparison Results

WOCKHARDT LTD.    Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT LTD. SHASUN PHARMA WOCKHARDT LTD./
SHASUN PHARMA
 
P/E (TTM) x -15.1 123.9 - View Chart
P/BV x 2.5 8.5 29.0% View Chart
Dividend Yield % 1.3 0.2 570.7%  

Financials

 WOCKHARDT LTD.   SHASUN PHARMA
EQUITY SHARE DATA
    WOCKHARDT LTD.
Mar-17
SHASUN PHARMA
Mar-14
WOCKHARDT LTD./
SHASUN PHARMA
5-Yr Chart
Click to enlarge
High Rs1,12994 1,198.5%   
Low Rs62746 1,375.0%   
Sales per share (Unadj.) Rs363.1214.2 169.6%  
Earnings per share (Unadj.) Rs-20.45.3 -383.2%  
Cash flow per share (Unadj.) Rs-7.015.8 -44.1%  
Dividends per share (Unadj.) Rs10.001.00 1,000.0%  
Dividend yield (eoy) %1.11.4 79.6%  
Book value per share (Unadj.) Rs301.853.3 565.8%  
Shares outstanding (eoy) m110.5556.62 195.2%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x2.40.3 740.8%   
Avg P/E ratio x-42.913.1 -327.8%  
P/CF ratio (eoy) x-125.94.4 -2,848.8%  
Price / Book Value ratio x2.91.3 222.0%  
Dividend payout %-48.918.7 -261.0%   
Avg Mkt Cap Rs m97,0633,958 2,452.5%   
No. of employees `0006.8NA-   
Total wages/salary Rs m9,6652,164 446.7%   
Avg. sales/employee Rs Th5,931.8NM-  
Avg. wages/employee Rs Th1,428.1NM-  
Avg. net profit/employee Rs Th-334.0NM-  
INCOME DATA
Net Sales Rs m40,14612,127 331.1%  
Other income Rs m1,143229 498.1%   
Total revenues Rs m41,28912,356 334.2%   
Gross profit Rs m1281,009 12.7%  
Depreciation Rs m1,489594 250.9%   
Interest Rs m2,253415 542.7%   
Profit before tax Rs m-2,472230 -1,076.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-211-73 290.3%   
Profit after tax Rs m-2,260302 -748.2%  
Gross profit margin %0.38.3 3.8%  
Effective tax rate %8.5-31.7 -27.0%   
Net profit margin %-5.62.5 -226.0%  
BALANCE SHEET DATA
Current assets Rs m46,1606,884 670.5%   
Current liabilities Rs m19,2588,456 227.7%   
Net working cap to sales %67.0-13.0 -517.1%  
Current ratio x2.40.8 294.4%  
Inventory Days Days10162 163.5%  
Debtors Days Days94108 87.4%  
Net fixed assets Rs m40,1654,970 808.1%   
Share capital Rs m553113 487.8%   
"Free" reserves Rs m32,8142,875 1,141.4%   
Net worth Rs m33,3673,020 1,104.8%   
Long term debt Rs m31,9031,817 1,755.4%   
Total assets Rs m89,68713,347 672.0%  
Interest coverage x-0.11.6 -6.3%   
Debt to equity ratio x1.00.6 158.9%  
Sales to assets ratio x0.40.9 49.3%   
Return on assets %05.4 -0.2%  
Return on equity %-6.810.0 -67.7%  
Return on capital %-0.313.3 -2.5%  
Exports to sales %046.4 0.0%   
Imports to sales %014.2 0.0%   
Exports (fob) Rs mNA5,622 0.0%   
Imports (cif) Rs mNA1,728 0.0%   
Fx inflow Rs m9,1215,843 156.1%   
Fx outflow Rs m2,1332,173 98.2%   
Net fx Rs m6,9883,669 190.4%   
CASH FLOW
From Operations Rs m-2,695398 -677.7%  
From Investments Rs m-6,863-1,635 419.7%  
From Financial Activity Rs m12,5451,309 958.7%  
Net Cashflow Rs m3,01071 4,227.9%  

Share Holding

Indian Promoters % 74.5 39.2 190.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.3 3.6 63.9%  
FIIs % 7.7 17.6 43.8%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 39.6 38.9%  
Shareholders   67,757 20,750 326.5%  
Pledged promoter(s) holding % 0.0 12.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT LTD. With:   DR. REDDYS LAB  STERLING BIOTECH  ASTRAZENECA PHARMA  VENUS REMEDIES  IPCA LABS  

Compare WOCKHARDT LTD. With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Trade Marginally Higher; IT Stocks Witness Buying Interest(11:30 am)

Stock markets in India are presently trading marginally higher. Sectoral indices are trading on a mixed note with stocks in the IT sector and FMCG sector witnessing maximum buying interest.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT LTD. SHARE PRICE


Feb 21, 2018 01:07 PM

TRACK WOCKHARDT LTD.

  • Track your investment in WOCKHARDT LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT LTD.

WOCKHARDT LTD. 5-YR ANALYSIS

COMPARE WOCKHARDT LTD. WITH

MARKET STATS